A
1. Valproate-Induced Inositol Depletion via
Inhibition of Myo-Inositol-1-Phosphate (MIP) Synthase Activity
G. Agam, G. Shaltiel , A. Shamir, M.L.
Greenberg, R.H. Belmaker
2. The Follow-Up Study of Persistent Tardive
Dyskinesia in Patients with Bipolar Disorder
F. Akdeniz; M.A. Noyan; H. Coskunol H
3. Clinical Characterization of Acute Mania: Data
in 1090 patients – “EPIMAN-II”
H.S. Akiskal, E.G. Hantouche, J.M. Azorin, S.
Lancrenon, L. Châtenet-Duchêne, J.F. Allilaire
4. A 1H-MRS Study of the Anterior Cingulate Gyrus
in Euthymic Bipolar Patients Taking Lithium
J.A.M. Amaral, B. Lafer, R.S. Tamada, C.K. Issler,
G.G. Cerri, C.C. Castro
5. Interpersonal Problems of Bipolar Patients - A
Cross-cultural Assessment Study
A.C.F. Andrade,
E. Frank, F. L. Neto, B. Lafer, C.T.L. Moraes
6. When Bipolar Disorder Is in Order
A.C.F. Andrade, E. Frank, H.A. Swartz
7. Bipolar Disorder (BD) Specific Reduction of
Transient Receptor Potential Channel (TRPC) 3 Levels in B-Lymphoblasts (BLCLs)
Exposed Chronically to Lithium
S. Andreopoulos, M. Wasserman, P.P. Li, J.J. Warsh
8. Systematic Comparison between Mood-Congruent
versus Mood-Incongruent Psychotic Features in Acute Mania: Data on 1090 patients
– “EPIMAN-II”
J.M. Azorin, E.G. Hantouche, H.S. Akiskal, S.
Lancrenon, L. Châtenet-Duchêne, J.F. Allilaire
B
9. Does Prophylaxis-Delay in Bipolar Disorder
Influence Outcome? A Long-Term Study of 147 Patients
C. Baethge, M. Bauer, M.N. Smolka, A. Berghöfer,
P. Grof, B. Müller-Oerlinghausen
10. Prophylaxis of Schizoaffective Disorder with
Lithium or Carbamazepine: Outcome After Long-Term Follow-Up
C. Baethge, T. Bschor, B. Müller-Oerlinghausen,
A. Berghöfer, M.N. Smolka, M. Bauer
11. Dysphoric Mania: A Controlled Study of the
Benefits of Olanzapine Combined with Valproate or Lithium
R.W. Baker, E. Brown, M. Tohen, L.M. Schuh, P.
Trzepacz
12. Patterns of Weight Gain in Bipolar Patients
Treated with Olanzapine or Divalproex
R. W. Baker, E. Brown, L. Schuh, J. Pinaire, M.
Tohen
13. A New Instrument for Assessing Barriers to
Health Care Access
M.S. Bauer, W.O. Williford, P. Connor, L. McBride,
K. McBride
14. Mood Patterns in Patients with Bipolar
Disorder: Influence of Antidepressants
M. Bauer, N. Rasgon, P. Grof, L. Gyulai,
T. Glenn, P.C. Whybrow
15. Number of Medications and Self-Reported Mood
in Patients with Bipolar Disorder
M. Bauer, P. Grof, N. Rasgon, L. Gyulai,
T. Glenn, P. C. Whybrow
16. Comprehensive Nutrition Care to Prevent
Bodyweight Gain and Metabolic Dysfunction Associated with Olanzapine Treatment
S. Beaulieu, M. Rabin, C. Roll, I. Losna, T.
Baptista, M.A. Wolf, G. Turecki, P. Assalian, R. Tempier
17. Could Atypical Depression be Defined Only by
Presence of Reversed Vegetative Symptoms?
F. Benazzi
18. High Frequency of Bipolar Spectrum and
Depressive Mixed State in Depressed Outpatients
F. Benazzi
19. A Comparison of Medical Chart Diagnosis with
SCID Consensus Diagnosis among Bipolar Disorder Patients
S. M. Berns, J. Jaeger, R. Ianuzzo, A. Malhotra,
G. Petrides, P. DeRosse, G. Musso, S. Abdelmessih
20. Neurocognitive Impairment in Bipolar and
Schizophrenia Inpatients
S.M. Berns, J. Jaeger
21. Prophylactic Efficacy of Oxcarbazepine in
Bipolar Disorder
D.A. Berv, J. Klugman, D.J.
Hsu, K.J. Rosenquist, S.N. Ghaemi
22. Risperidone and Affective Symptoms in
Children with Disruptive Behavior Disorders
J. Biederman, S. Faraone,
E. Mick, S. van Patten, G. Pandina, Y. Zhu,
G. Gharabawi
23. Cognitive and Sensory Vulnerabilities in
Children with Early Onset Bipolar Disorder
C. Boczko, N.B. Austin, B. Gerson
24. Treatment Satisfaction and Compliance with
Risperidone Use in Patients with Bipolar Disorder
S. Bolge, D.M. Meletiche
25. Concomitant Use of Lamotrigine and Valproate
in Bipolar I Disorder
C. Bowden, J.
Calabrese, G. Sachs, G. Evoniuk, A. Metz
26. In Vivo Effects of Lithium in Dorso-Lateral
Prefrontal Cortex in Healthy Human Subjects: a 1H MRS study
P. Brambilla, J.A. Stanley, R.B. Sassi,
M.A. Nicoletti, A.G. Mallinger, M.S. Keshavan, JC.
Soares
27. Quetiapine vs Placebo for Acute Mania
Associated with Bipolar Disorder (STAMP 1)
M. Brecher, K. Huizar
28. Declarative Memory, Mood and Proton Magnetic
Resonance Spectroscopy in Patients Receiving Chronic Prednisone Therapy
E.S. Brown, A. Frol, L. Bobadilla, D.A. Khan, M.
Hanczyc, J. Fleckenstein, E. Babcock, S. Mahadi, V.A. Nejtek, D. Gleason, H.
Dhillon, M. Cullum
29. Impact of Childhood Abuse on Disease Course
in Veterans with Bipolar Disorder
G.R. Brown, M.S. Bauer,
L. McBride, W. Williford, P. Connor
30. Double-blind Comparison of High-Dose
L-Thyroxine and Thyroxine-Triiodothyronine- Combination in Patients with
Prophylaxis-Refractory Affective Disorders
T. Bschor, J. Wolf, U. Köberle, B. Müller-Oerlinghausen,
M. Bauer
31. The Effect of Circadian Rhythm Disruption on
Mood in a Subgroup of Patients with Bipolar Affective Disorder
L. Bukhari, N. Samavedy, A. Anand, A. Mayeda, W.
Lawson, J. I. Nurnberger, Jr.
C
32. Axis I Psychiatric Comorbidity in 44
Brazilian Outpatients with Bipolar Disorder
S. C. Caetano, B.Lafer, C. K. Issler, R. S.
Tamada, J. A. Amaral
33. Lamotrigine Controls Bipolar Depression
without Destabilizing Mood: An Analysis of Data from Eight Placebo-Controlled
Trials
J. Calabrese, L. Yatham, T. Suppes,
S. McElroy, J.F. Goldberg, F. Goodwin, C.
Bowden
34. A 20-month, Double-blind, Maintenance Study
of Lithium vs. Divalproex Monotherapy in Bipolar I And II Disorder Accompanied
by Rapid Cycling
J.R. Calabrese, M. Shelton, D. Rapport, E. Youngstrom, E. Shirley, O. Elhaj, K. Packer, S. Bilali, R.L. Findling
35. Remission with Risperidone in Combination
with Mood Stabilizers in Acute Bipolar Mania
C. Canuso, Y. Zhu, C. Bossie,
F. Grossman
36. Long-acting Risperidone Reduces Symptoms of
Depression and Anxiety in Patients with Schizophrenia and Schizoaffective
Disorder
C. Canuso, C. Bossie, Y. Zhu, R. Lasser
37. Elevated Homocysteine and Reduced Folate
Levels in Bipolar Patients Treated with Valproic Acid
F. Cassidy, J. C. Ritchie, B. J.
Carroll
38. Group Music Therapy and Medication
Compliance: A Controlled Study on Bipolar Patients and Patients with Other
Psychotic Disorders
R.C. Castilla, J.M. Perel
39. Clinical Experience with Oxcarbazepine in 56
Hospitalized Psychiatric Patients
F. Centorrino, M.J. Albert, J.M. Berry, J.P.
Kelleher, V. Fellman, G. Line, A.E. Koukopoulos,
J. Kidwell, K.V. Fogarty, and R.J Baldessarini
40. Examining Social Rhythm Regularity to Predict
Affective Episodes in Bipolar Spectrum Individuals
G. H. Chang, L. B. Alloy, L.Y. Abramson
41. Bipolar Disorder with/without Suicidal
Ideation/Behavior
C.A. Chessick, M.H. Allen, J. Goldberg
42. Risperidone Augmentation in Rapid-Cycling
Bipolar Disorder
C. Coconcea, P. Delgado, M.
Shelton, L. Amawi, J. Calabrese
43. Group Psychoeducation Enhances Serum Lithium
Levels Stability
F. Colom, E. Vieta, M. Reinares, A.
Martinez-Arán, J. Sánchez-Moreno, C. Torrent
44. Oxcarbazepine for Hypomania in Bipolar II
Disorder
M. Comes, E. Vieta, A. Benabarre, J.M. Goikolea,
B. Corbella, F. Colom
D
45. Effects of Lamotrigine on Neurocognitive
Measures in Bipolar I Patients
K.H. Davis, L.N. Yatham,
A. Khan, L.D. Ginsberg, G.M. Asnis, F.K.
Goodwin
46. Characteristics of Nonverbal Memory
Impairment in Euthymic Bipolar Disorder
T.D. Deckersbach, S. McMurrich, J. Ogutha,
N. Reilly-Harrington, S.L. Rauch, G. Sachs
47. Divalproex for the Treatment of Aggression
Associated with Adolescent Mania
M.P. DelBello, M. Schwiers, H.L. Rosenberg, S.M.
Strakowski
48. The Cortisol Awakening Response in Bipolar
Illness: A Pilot Study
D. Deshauer, P. Grof,
A. Duffy, M. Alda, E. Grof, J. Albuquerque
49. Oxcarbazepine Efficacy/Safety in Bipolar
Disorder: A Retrospective Review of 249 Patients
D.A. Deutschman, D.H. Deutschman, J.S. Chalakian
50. Olanzapine in the Treatment of Rapid-Cycling
Bipolar Disorders: An Open Prospective Study
R. D’Souza, N. Keks, M. Scurrah
51. An Open Randomized Control Study Using a
Spiritually Augmented Cognitive Behavior Therapy for Demoralization and
Treatment Adherence in Patients with Bipolar I Depression
R. D’Souza, N. Keks,
D. Rich, I. Diamond, K. Godfery
52. Onset of Action of Olanzapine/Fluoxetine
Combination in Bipolar Depression
S. Dubé, G. D. Tollefson, M.E. Thase, S.D. Briggs, L.E. Van Campen,
M. Case, M. Tohen
53. A Prospective Study of the Offspring of
Bipolar Parents Responsive and Non-Responsive to Lithium Treatment
A. Duffy, M. Alda, D. Deshauer, C.
Robertson, S. Kutcher, P. Grof
54. Treatment Resistant Bipolar Disorder
D.L. Dunner, D. Vo, S. Friedman
55. Prevalence and Clinical Characteristics of
Mania in Hospitalized Adolescents
J. Dyl, J.I. Hunt, A. Spirito
E
56. Antidepressant-Induced Chronic Irritable
Dysphoria (ACID)
R.S. El-Mallakh, A. Karippot, M. Welter
57. Endogenous Cardenolide Production Bipolar
Subjects and Normal Controls in Response to Prolonged Physical Activity
R.S. El-Mallakh, M. Stoddard, M. Adnan El-Masri,
S. Jortani, R. Valdes, Jr.
58. PRIVATE Expression of Sodium Potassium ATPase Alpha-Isoforms
in Neuronal and Glial Cells in Culture
M.A. El-Masri, L. Habeeb, X. Li, R.S.
El-Mallakh
59. Inositol Augmentation of Mood Stabilizers for
Bipolar Depression
E.A. Evins, A. Nierenberg, L. Eisner, J. Ogutha,
L. Grandin, C. Demopulos, G. Sachs
F
60. Phenomenology and Course of Pediatric Bipolar
Disorder
G.L. Faedda, I.P. Glovinsky, N.B. Austin, N. Aristitzabal, R.J. Baldessarini
61. Treatment-emergent Mania in Pediatric Bipolar
Disorder
G.L. Faedda, I.P. Glovinsky, N.B. Austin, R.J. Baldessarini
62. Depressive Symptoms during Mania
A. Fagiolini, E. Frank, D. Novick, P. Rucci, D.J. Kupfer
63. Hypothyroidism in 175 Patients with Bipolar I
Disorder
A. Fagiolini, D.C. Cook, E. Frank, D.J. Kupfer
64. Divalproex Sodium versus Placebo in the
Treatment of Youths at Genetic High-Risk for Developing Bipolar Disorder
R.L. Findling, J.R. Calabrese, E.A. Youngstrom
65. Combination Divalproex Sodium and Lithium
Treatment in Pediatric Bipolarity
R.L. Findling, J.R. Calabrese, E.A. Youngstrom
66. Investigating the Functional Interface
between Dorsal and Ventral Prefrontal Circuitry in Bipolar Disorder
S. Frangou, V. Raymont, J. Kingston, S. Shergill
67. Mania, Menstrual Cycle and Lithium: Interactions and Clinical Implications
A.R. Fraser
68. Comorbidity and Disability in Bipolar
Disorder
M.A. Frye, L.L. Altshuler, J.W. McKowen, M.J.
Gitlin, R.C. State, A.H. Fan
69. Previous Episode Burden and Response to
Treatment in Bipolar I Disorder
M. Frye, T. Ketter, J. Goldberg, Z. Antonijevic,
J. Calabrese
G
70. BALANCE: Progress Report of a Randomized
Trial of Maintenance Treatment for Bipolar Disorder
J.R. Geddes, J.M. Rendell, on Behalf of the
BALANCE Investigators
71. Efficacy and Acceptability of Lithium in
Relapse Prevention in Bipolar Disorder
J.R. Geddes, S. Burgess, K. Jamison, K. Hawton,
G.M. Goodwin
72. Effects of Newer and Older Antidepressants in
Bipolar Depression
S.N. Ghaemi, K.J. Rosenquist, J.Y. Ko, F.K.
Goodwin,
R.J. Baldessarini
73. Quetiapine for Rapid-Cycling Bipolar
Disorder: A Long-term Follow-up Study
S.N. Ghaemi, J.F. Goldberg, C.A.Henry, K.J. Rosenquist, J.Y. Ko, D.J.
Hsu, S.J. Wenze, M.M. Wankmuller
74. Cognitive Impairment in Late-Life Bipolar
Disorder
A.G. Gildengers, M.A. Butters, K. Seligman, P.R.
Houck, M.D. Miller, B.H. Mulsant, C.F. Reynolds III
75. Clinical Time Cost of a Nurse-Psychiatrist
Disease-Management Program for Bipolar Disorder
H.A. Glick, M.S. Bauer, W.O. Williford, B. Kinosian
76. The Regional Cerebral Blood Flow Changes in
Major Depressive Disorder with and without Psychotic Features: A 99mTc- HMPAO
SPECT Study
A.S. Gonul, M. Kula, A. Bilgin, A. Tutus, A. Oguz
77. Mania Remission Rates in a Randomized
Controlled Trial of Risperidone
S. Gopal, M.L. Kramer, M.K. Olsen,
D.C. Steffens
78. The Individual Therapeutic Plan (ITP) for
Bipolar Spectrum Disorders
R. Graef, M. Enos
79. Symptomatic Response to Prophylaxis Treatment
in Bipolar I Disorder
L. Gyulai, J. Zajecka, C. Bowden,
J. Calabrese, R. Leadbetter, W. Saunders
H
80. Efficacy of Mood Stabilizers Augmentation in
Strict Unipolar Depression
E.G. Hantouche, J.F. Allilaire, S. Lancrenon, J.M. Azorin, M.L. Bourgeois, D. Sechter, L. Chatenêt-Duchêne,
H.S. Akiskal
81. Habits and Use of Anti-manic Drugs in a
Naturalistic Multi-Site Survey
E.G. Hantouche, B. Lachaux, L. Vallier
82. European Mania in Bipolar Longitudinal Evaluation of
Medication (EMBLEM) Study: Study Design and Recruitment of a 2-year,
Pan-European, Observational Health Outcomes Study in Bipolar Disorder
J.M. Haro, I. Goetz, C. Reed, W.A. Nolen, J.
van Os, E. Vieta, J. Angst on behalf of the EMBLEM Advisory Board
83. Burden of Manic versus Depressive Symptoms in
Subjects with Bipolar Disorder
R.M.A. Hirschfeld, J.R. Calabrese, M.A. Frye, K.D.
Wagner, M. Reed
84. Rapid Antimanic Effect of Risperidone
Monotherapy: A 3-Week Multicenter, Randomized, Double-blind, Placebo-controlled
Trial
R.M.A. Hirschfeld, P.E. Keck, K. Karcher, M.L.
Kramer, F. Grossman
85. If You Want a Job Done Properly, Do It
Yourself - Setting up a County-wide Lithium Database
B. Holmes, S. Bazire
86. Long Term Monitoring with the NIMH Lifechart
Method Improves the Course of Bipolar Illness–first Results from the German
Stanley Bipolar Treatment Network Centre
M. Hörn, C. Biedermann, S. Dittmann, Y. Grässlin, A. Forsthoff, S. Frey, B. Hummel, H. Grunze, L.O. Schärer, D.
Scherer-Klabunde, N. Strobl, S. Walser, J. Walden, J. M. Langosch
87. Ethyl-eicosapentaenoate (LAX-101): How May it
Work in Bipolar Depression?
D.F. Horrobin, C.N. Bennett and H. Murck
88. Patient Bias and Open Randomization in
Bipolar Trials
D.J. Hsu, F. Soldani, R.S. El-Mallakh, K.J. Rosenquist, F.K. Goodwin, S.N. Ghaemi
89. Clinical Features of Obsessive-Compulsive
Disorder in Patients with Bipolar Disorder
C.K. Issler, R.S. Tamada, J.A.M.S. Amaral,
A.M. Schwartzmann, R.G. Shavitt, B. Lafer, E.C. Miguel
90. Obsessive-Compulsive and Bipolar Disorder
Comorbidity: A Controlled Study
C.K. Issler, J.A.M.S. Amaral, R.S. Tamada,
A.M. Schwartzmann, R.G. Shavitt, E.C. Miguel, B. Lafer
J
91. Legal Complications of Bipolar Disorder
Accompanied by Alcohol, Cannabis, or Cocaine Abuse or Dependence
K.S. Jackson, M. Shelton, O. Elhaj, D. Rapport,
E. Youngstrom, K. Packer, S. Bilali, R. Findling, J. R. Calabrese
92. Diagnostic Confidence: A Comparison of Expert
Diagnostic Confidence Ratings for Consecutive SCID Research Diagnoses of Bipolar
Disorder and Schizophrenia
J. Jaeger, G. Petrides, D. O'Shea, R. Iannuzzo,
G. Musso, S. Abdelmessih, P. DeRosse, P. Czobor, A. Malhotra
93. Premorbid Adjustment in Bipolar Disorder:
Comparison with Schizophrenia
J. Jaeger, S.M. Berns, S. Uzelac
94. Comparison of Comorbid Psychiatric Disorders
in Youths with Bipolar I Disorder
J.M. Jerrell, M.A. Shugar
95. Quetiapine Monotherapy for Acute Mania
Associated With Bipolar Disorder (STAMP 1 and STAMP 2)
M. Jones,
K. Huizar
96. Direct Costs of Bipolar Disorder in Korea: A
Survey of National Health Care System
H.Y. Jung, S.I. Lee, D.H. Kim
K
97. Identifying BPSD versus ADHD in a Juvenile
Clinical Sample: Which Measure Does Best?
S.Y. Kahana, E.A. Youngstrom, C. Demeter, M.
Price, G.M. Woldorf, R.L. Findling, J.R. Calabrese
98. Concordance in Twins for DSM-IIIR Functional
Psychosis According to Proband Characteristics
S. Kalidindi, A. G. Cardno, R. M. Murray, P.
McGuffin
99. Randomized, Placebo-Controlled Trial of
Eicosapentanoic Acid (EPA) in Bipolar Depression
P.E. Keck, Jr., S.L. McElroy, M.P. Freeman, L.L.
Altshuler, M.A. Frye, R. Kupka, W. Nolen, H. Grunze,
J. Walden, K.D. Denicoff, G.S. Leverich, R.M.
Post
100. Randomized, Placebo-Controlled Trial of Eicosapentanoic Acid (EPA) in Rapid Cycling Bipolar Disorder
P.E. Keck, Jr., S.L. McElroy, M.P. Freeman, L.L.
Altshuler, M.A. Frye, J. Mintz, S. Hwang, R. Kupka, W. Nolen, H. Grunze, J. Walden, K.D. Denicoff G.S.
Leverich, R.M. Post
101. Effects of Lamotrigine on Quality of Life in
Patients with Bipolar I Disorder
S.H. Kennedy, M.H. Rapaport, F.W. Reimherr, K.H.
Davis
102. Affective Temperamental Features of Bipolar
Patients and Their First Degree Relatives: A Controlled Study
S. Kesebir, S. Vahip, H. Akiskal, Z. Yüncü,
M. Kocadere
103. Affective Temperaments and Clinical Features
of Bipolar Disorder
S. Kesebir, S. Vahip, H. Akiskal, Z. Yüncü
104. The Risk of Developing Diabetes in Patients
with Depression or Mania
L.V. Kessing, F.M.
Nilsson, V. Siesma, P. K. Andersen
105. Extended Release Carbamazepine in Bipolar
Disorders
T.A. Ketter, R.H. Weisler,
A.H. Kalali
106. Predictors of Response to Lithium and
Lamotrigine Prophylaxis in Bipolar I Disorder
T. Ketter, C. Bowden, T. Suppes,
J. Goldberg, Z. Antonijevic, R. Leadbetter
107. A 9-Week Extension of Risperidone
Monotherapy in Acute Bipolar Mania
S. Khanna, R.M.A. Hirschfeld, K. Karcher,
F. Grossman, M. L. Kramer
108. Risperidone Monotherapy in Acute Bipolar
Mania
S. Khanna, E. Vieta, B. Lyons, F.
Grossman, M. L. Kramer
109. Racial Differences in Burden of Psychiatric
and Substance Use Comorbidity
A. Kilbourne, M. Bauer, H. Pincus, W. Williford,
G. Kirk, T. Beresford
110. Life Stress and the Course of Early-Onset
Bipolar Disorder
E.Y. Kim, D.J. Miklowitz
111. Longitudinal Data Analysis of Bipolar
Patients by Mixed Model with Multiple Imputation
L. Kirisci, I. Salloum, J. Hayes, D. Fitzgerald
112. A Pilot Risk Evaluation of Lithium in
Pregnancy
E.A.M. Knoppert–van der Klein, I.L. van Kamp, F.J. Walther, A. Kramer, I.M. van Vliet,
F.G. Zitman
113. A Randomized Trial of an
Interpersonal/Cognitive Behavior Intervention for Preventing Bipolar Disorder in
Depressed Adolescents. Preliminary Results
F.J Kochman, E.G Hantouche, J.A Meynard, D.Bayart
114. Rapid and Non-Rapid Cycling Bipolar
Disorder: A Comparative Study Using Daily Prospective Mood Ratings in 539
Outpatients
R.W. Kupka, D.A. Luckenbaugh, R.M. Post, L.L.
Altshuler, K..D Denicoff, M.A. Frye, H. Grunze, P.E. Keck Jr, G.S. Leverich, S.L.
McElroy, T. Suppes, J. Walden, W.A. Nolen
115. Topiramate as Adjunctive Therapy to Mood
Stabilizers in Patients with Bipolar I or II Disorder
V. Kusumakar, R. McIntyre, C. Binder,
R. Riccardelli
L
116. Risperidone in Borderline Personality
Disorder
A. Lai
117. Long-Term Treatment of Bipolar Disorder:
Consideration of the Current State and Future Directions
R. Lasser, C. Kosik-Gonzalez, C. Bossie, G. Gharabawi
118. Oxcarbazepine as Add-on Treatment in
Patients with Bipolar Manic, Mixed or Depressive Episode
L. Lattanzi, A. Benedetti, S. Pini, G. Ceraudo,
L. Musetti, G. B. Cassano
119. To Compare the Efficacy and Safety of the
New Extended Release Divalproex Sodium with the Traditional Enteric-Coated
Divalproex Formulation in a Cross Sectional Group of Psychiatric Patients
R.B. Lehman
120. Elevated Homocysteine Levels in Euthymic
Bipolar Disorder Patients
J. Levine, Y. Osher, B-A Sela, R.H. Belmaker
121. Prophylactic Effects of Phenytoin in Bipolar
Illness: A Controlled Study
J. Levine, Y. Bersudsky, A. Mishory, M. Winokur,
R.H. Belmaker
M
122. Electroconvulsive Therapy in Treatment
Resistant Bipolar Disorder – Case Reports
M.B. Macedo-Soares, R.A. Moreno, S.P. Rigonatti,
B. Lafer
123. California Medicaid Costs of Atypical
Antipsychotics in Bipolar Disorder
J. Malkin, A. Grogg, A. McDermott, K. Sadik
124. Association and Linkage Studies of
Serotonergic Polymorphisms in Bipolar I Disorder Using Familial and Unrelated
Controls
H. Mansour, S. Ranade, L.K. Brar, K.V. Chowdari,
J. Wood, B. Devlin, D.J. Kupfer, V.L. Nimgaonkar
125. History of Trauma in a Community Sample of
Pediatric Bipolar Patients
W.R. Marchand, L. Wirth
126. Long Term Treatment of Bipolar I and II
Disorder with Valproic Acid Extended Release
D.B. Marcotte
127. Aripiprazole versus Placebo in Acute Mania
R. Marcus, P.E. Keck
Jr., A. Saha, T. Iwamoto, D. Jody, S. Tourkodimitris, D.G.
Archibald, R. Sanchez
128. Utilization and Cost of Atypical
Antipsychotics in Medicaid Patients with Depression
J. Markowitz, D.M. Meletiche
129. Cognitive Schemata of Bipolar Patients. Do
Women and Men Differ?
B. Marquart, C. Lex, K. Thau
130. Prevention of Mania is Prevention of
Subsequent Cognitive Impairment
A. Martinez-Arán, C. Torrent, F. Colom, M.
Reinares, J. Sánchez-Moreno, E. Vieta
131. Neuropsychological Profile of Children with
Juvenile-onset Bipolar Disorder
S. Mattis, D.F. Papolos
132. Cost-Effectiveness of Atypical
Antipsychotics in Acute Bipolar Mania
L.J. McGarry, A.P. Bird, D. Thompson, P.
Wang, S.C. Martin, M.C. Weinstein
133. Aripiprazole vs. Placebo in Acute Mania:
Safety and Tolerability Pooled Analysis
R.D. McQuade, R. Marcus, R. Sanchez,
A. Saha, D. Jody, S. Tourkodimitris, W.
Carson, D.G. Archibald
134. Impact of Weight Gain on Health-Related
Quality of Life (HRQL) of Bipolar Patients
D.M. Meletiche, S. Bolge
135. A Randomized Controlled Trial of Cognitive
Behavior Therapy and Supportive Therapy for Bipolar Disorders
T.D. Meyer, M. Hautzinger
136. Quality of Life in Bipolar Disorder: A
Review of the Literature
E.E. Michalak, L.N. Yatham, G. Ineson, R.W. Lam
137. MRI Study of Thalamus Volumes In Adolescent
Bipolar Patients
E. S. Monkul, D. Spence, R.B. Sassi, D.
Axelson, P. Brambilla, M.A. Nicoletti, J.P. Hatch, M. Keshavan, N. Ryan,
B. Birmaher, J.C. Soares
138. Prevalence and Characteristics of the
Bipolar Spectrum in a Sample of a Defined Area of the City of São Paulo (Brazil)
D.H. Moreno, L.H. Andrade
139. Quetiapine Adjunctive Therapy for Acute
Mania Associated With Bipolar Disorder (SIAM)
J. Mullen, N. Devine, D. Sweitzer
140. Quetiapine in Combination with Mood
Stabilizer for the Treatment of Acute Mania Associated with Bipolar Disorder
J. Mullen, B. Paulsson
141. Symptoms of Bipolar Disorder in Adult-Onset
versus Juvenile-onset Patients
K.L. Mullen, D.J. Miklowitz
142. Oxcarbazepine for the Treatment of Bipolar Disorder
R.A. Munoz
N
143. The Role of Negative Parenting and Inferential Feedback in Predicting
Bipolar Spectrum Disorder Status and Negative Cognitive Style
A. M. Neeren, L.B. Alloy, L.Y. Abramson
O
144. Prevalence of Bipolar Disorder in a Total
Population of Swedish Adolescents
G.I. Olsson, A-L. von Knorring
145. Characteristics of Patients Treated with Gabapentin Referred to a Bipolar Specialty Clinic
M. Ostacher, H. Schloss, L. Eisner, D. Borrelli,
C. Demopulos, G. Sachs, A. Nierenberg
146. Quality of Life in Euthymic Bipolar Patients
and their Family Members: A Comparison with Diabetics and Normal Controls
A. Özerdem, B. Çakaloz, S. Topkaya, A. Koçyigit,
M.Y lmaztürk, B.B. Afsar, A.G. Aydar, H. Fidaner, A. Çömlekçi, S. Yesil
P
147. Efficacy of Electroconvulsive Therapy in Unipolar
or Bipolar Depression: A Meta-Analytic Review
D. Pagnin, V. De Queiroz, S. Pini, G.B. Cassano
148. Group Mindfulness Based Cognitive Therapy
for Bipolar Disorder
A. Palmer, S. Tucker,
A. Swift
149. The Immediate Processing of Schema
Discrepant Meaning in Bipolar Disorder
A. Palmer, P. Barnard
150. Antidepressant-Induced Adverse Effects in
Juvenile-onset Bipolar Disorder
D. F. Papolos, R. Greenberg, S. Tresker, K.
Freeman
151. The Bipolar Treatment Optimization Program
S.V. Parikh, S.H. Kennedy
152. Psycho-Education versus Cognitive-Behavioural Therapy for Bipolar
Disorder
S.V. Parikh, A. Zaretsky, I. Patelis-Siotis,
L. Yatham, S. Beaulieu
153. Quetiapine Monotherapy versus Placebo For Acute Bipolar Mania (STAMP
2)
B. Paulsson, K. Huizar
154. An Evidence-Based Pharmacotherapy Algorithm in Pediatric Bipolar
Disorder
M.N. Pavuluri, D. Henry, J. Carbray, G. Sampson, M. Naylor, P.G.
Janicak
155. A Prospective Comparison of Risperidone versus Mood Stabilizers in
Pediatric Bipolar Disorder
M.N. Pavuluri, D. Henry, J. Carbray, G. Sampson, M. Naylor, P.G.
Janicak
156. Improving Patient and Primary Care Understanding of Bipolar
Variations
J.R. Phelps
157. Separation Anxiety Symptoms in Patients with Bipolar Disorder
S. Pini, P. Iazzetta, M. Abelli, G.B. Cassano
158. Retrospective Chart Review on the Use of Oxcarbazepine in Patients
with Bipolar Disorder
D.E. Platt, F.A. Munasifi, L.M. McKay
R
159. Gender Differences in the Mood Patterns of Patients with Bipolar
Disorder
N. Rasgon, M. Bauer, P. Grof,
L. Gyulai, T. Glenn, P.C. Whybrow
160. Characteristics of Responders in a Community-Based, Collaborative
Randomized Clinical Trial of Cognitive Behavioral Group Therapy for Bipolar
Disorder
R. Reiser, T.G. Shaffer, M. Basco, L.Thompson
161. Feasibility and Acceptance of a Randomized Clinical Trial of
Cognitive Behavioral Group Therapy for Bipolar Disorder in a Community Mental
Health Setting
R. Reiser, T.G. Shaffer, C. Sartor, S. Burns, L. Thompson
162. Systematic Review of Olanzapine Alone or in Combination for Acute
Mania
J.M. Rendell, H.J. Gijsman, P. Keck, G.M. Goodwin, J.R. Geddes
163. Extrapyramidal Symptoms with Atypical Neuroleptics in Bipolar
Disorder
K.J. Rosenquist, D.J. Hsu, F. K. Goodwin,
S.N. Ghaemi
164. The Mood Spectrum in Unipolar and Bipolar Patients
P. Rucci, G.B. Cassano, E. Frank, A. Fagiolini, L. Dell’Osso, M.K.
Shear, D.J. Kupfer
165. Mindshifting: A Family’s Call for Action
N. L. Rutter
166. Clinical Presentation of Bipolar Patients with and without Co-Morbid
Diabetes Mellitus
M. Ruzickova, C. Slaney, J. Garnham, M. Alda
167. Brain Derived Neurotrophic Factor Gene Polymorphism and Prefrontal
Function in Bipolar Patients
J.K. Rybakowski, A.Borkowska, P.M.Czerski,
M.Skibinska, J.Hauser
168. The Frequency of Bipolar Mood Disorder among Polish Psychiatric
Depressive Outpatients
J.K.Rybakowski, A.Kiejna
S
169. Effects of Lithium and Lamotrigine Prophylaxis Therapy on Body Weight
in Patients with Bipolar I Disorder
G. Sachs, A.H. Young, L. Ginsberg,
J. Calabrese, C. Bowden, Z. Antonijevic
170. Florida Medicaid Costs of Atypical Antipsychotics in Bipolar Disorder
K. Sadik, A. Grogg, A. McDermott,
J. Malkin
171. Combined Naltrexone Valproate in Bipolar Alcoholics: A Randomized,
Open-label, Pilot Study
I.M. Salloum, J.R. Cornelius, S. Chakravorthy
172. Efficacy of Valproate in Bipolar Alcoholics: A Double Blind,
Placebo-controlled Study
I.M. Salloum, J.R. Cornelius, D.C. Daley, L. Kirisci, J. Himmelhoch,
M.E. Thase
173. The Subgenual Prefrontal Cortex of Adolescent Bipolar Patients: A
Morphometric MRI Study
M. Sanches, R.B. Sassi, D. Axelson,
M. Nicoletti, P. Brambilla, J.P. Hatch,
M.S. Keshavan, N. Ryan, B. Birmaher, J.C.
Soares
174. Aripiprazole vs. Haloperidol for Maintained Treatment Effect in Acute
Mania
R. Sanchez, M. Bourin, P. Auby,
R. Swanik, R. Marcus, R.D. McQuade, T.
Iwamoto, E. Stock
175. The Inventory of Depressive Symptomatology – German Translation and
Validation of Self-rated Assessment in a Sample of Bipolar and Unipolar Patients
L.O. Schaerer, Y. Graesslin, N.C. Biedermann, S. Walser, G. Valerius,
C. Born, M.C. Strobl, S. Frey, V. Hartweg, M. Graf, M. Hoern, J. Walden, J.M.
Langosch
176. Effect of Antidepressant Use on Admissions
to Hospital among Elderly Bipolar Patients
A. Schaffer, M. Mamdani, A. Levitt, N. Herrmann
177. Mood Activating Effects of Opioid
Analagesics in Patients with Bipolar Disorder
C.B. Schaffer, T.E. Nordahl, L..C. Schaffer,
C.A. Hargis
178. The Use of Oxcarbazepine in Refractory
Bipolar Outpatients
C.B. Schaffer, L.C. Schaffer, J.L. Howe
179. Phenomenology of Rapid Cycling Bipolar
Disorder: Data from the First 500 Participants in the Systematic Treatment
Enhancement Program for Bipolar Disorder
C.D. Schneck, D.J. Miklowitz, J.R.
Calabrese, M.H Allen, M.R. Thomas, S.R. Wisniewski, Sachiko
Miyahara, M.D. Shelton, T.A. Ketter, J.F. Goldberg, C.L.
Bowden, G.S. Sachs
180. Cortical Gray and White Matter Volume and
Cognitive Function in Bipolar Disorder
D.B. Schnur, S. Smith, E. Hazlett, M.S. Buchsbaum
181. Galantamine for Cognitive Dysfunction in
Bipolar Disorder
E. Schrauwen, C. Henry, J.D. Hegarty, S.N. Ghaemi
182. Long-Term Lithium plus Lamotrigine
Combination Treatment of Bipolar Disorder
E. Schrauwen, J. Klugman, D.A. Berv, F.K.
Goodwin, S.N. Ghaemi
183. Characteristics of Episodic Memory
Impairments in Bipolar Disorder and Schizophrenia
S.G. Schütz, T. Deckersbach, T.D. Meyer,
S. Rauch, D.C. Goff, G.S. Sachs
184. Symptom Dimensions in Bipolar Disorder,
Schizoaffective Disorder and Schizophrenia: Factor Analysis of the Positive and
Negative Syndrome Scale among an Epidemiologically Complete Population
P.J. Scully, J.M. Owens, A Kinsella, J.L.
Waddington
185. Ideal Treatment from the Point of View of
Patients
M. Selo
186. The Daily-Life Creativity and Bipolar
Disorders: A Study in a Brazilian Sample of Patients, their Relatives and Normal
Controls
F. Shansis, M. Fleck, I. Izquierdo, B. Chait, B.
Mattevi, G. Maldonado, M. Berlim, C. Frank, A. Luzardo, E. Grevet
187. Which is the Best Mania Rating Scale? A
Comparative Study of Psychometric Properties of Young, CARS-M and Bech-Rafaelsen
Scales
F. Shansis, M. Fleck, I. Izquierdo, A.
Schwartzhalpt, E. Chachamovich, E. Grevet, B. Mattevi, G. Maldonado, M. Berlim
188. Protective Effect of Pregnancy on Bipolar
Disorder
V. Sharma, A. Smith, M. Khan
189. Substance Use Disorders and Their Response
to Treatment in Dual Diagnosis Bipolar Disorder
M. Shelton, O. Elhaj, D. Rapport, E. Youngstrom,
K. Packer, K.S. Jackson, S. Bilali, R. Findling, J.R. Calabrese
190. Growth Hormone Response to Zolmitriptan in
Acute Manic Patients
I.S. Shiah, S.N.Yang, L.J. Shen, C.K. Chen, S.Y.
Huang, H.J.Yang
191. Lithium Attenuates the Effects of Dextro-amphetamine
in Volunteers: An fMRI Study
P.H. Silverstone, M. Wilson, A. Wilman
192. Lithium, but Not Valproate Increases NAA
Concentrations in Bipolar Patients: An MRS Study
P.H. Silverstone, R.H. Wu, T. O’Donnell, M.
Ulrich, S.J. Asghar, C.C. Hanstock
193. The Clinical Knowledge and Research
Methodology Audit (Clinkarma) Study: Preliminary Evidence-based Assessment of
Recent Literature on Bipolar Disorder Research
F. Soldani, S.N. Ghaemi,
R.J. Baldessarini
194. Mania in the Swedish Twin Registry:
Criterion Validity and Prevalence
F. Soldani, P.F.
Sullivan, N.L. Pedersen
195. Phenomenology of Pediatric Bipolar Disorder:
Findings from a Pilot Project
A.A. Sood, J. Linker, N. Geller
196. Impulsivity: The Link Between Bipolar
Disorder and Substance Abuse
A.C. Swann, P.J. Pazzaglia, D.M. Dougherty, F.G.
Moeller
197. Psychosocial Functioning in Bipolar I
Disorder: Does Psychotherapy Help?
H.A. Swartz, E. Frank, P.R. Houck, D.J. Kupfer
T
198. Outcome of Antidepressant-induced Mania: A
Controlled Study
R.S. Tamada, C.K. Issler, J.A.M.S. Amaral, B.
Lafer
199. Modifying Focused Family Therapy for
Adolescents with Bipolar Disorder
D.O. Taylor, D.J. Miklowitz, E. L. George, D. Axelson, B. Birmaher,
D. Brent
200. Olanzapine’s Efficacy for Relapse Prevention
in Bipolar Disorder: A Randomized Double-Blind Placebo-Controlled 12-Month
Clinical Trial
M. Tohen, C. Bowden, J. Calabrese, J. C-Y
Chou, T. Jacobs, R.W. Baker, D. Williamson, A.R.
Evans
201. Olanzapine versus Lithium in Relapse
Prevention in Bipolar Disorder: A Randomized Double-blind Controlled 12-month
Clinical Trial
M. Tohen, A. Marneros, C. Bowden, W. Greil,
A. Koukopoulis, H. Belmaker, T. Jacobs, R.W. Baker, D. Williamson, A.R.
Evans, M. Dossenbach, G. Cassano
202. A Rating Scale for the Assessment of Eating
Dysfunctions in Bipolar Disorders (BEDS)
C. Torrent, E. Vieta, J.A. Crespo, A. González-Pinto,
J. Del Valle, J.M. Olivares, A. Rodriguez, C. De Arce, L. Sánchez-Planell, F.
Colom
V
203. Affective Temperamental Features in Turkey:
Findings from the Validity and Reliability Study of TEMPS-A Turkish Version
S. Vahip, S. Kesebir, M. Kocadere, O. Yazici,
H. Akiskal
204. The Impact of Positive Family History on
Affective Temperamental Features in Bipolar Patients and Their First Degree
Relatives: A Controlled Study
S. Vahip, S. Kesebir, H. Akiskal,
Z. Yüncü
205. Personality Changes during Light Therapy in
Bipolar Patients
E.M. Van Gent, G.J.Bonte
206. A Counseling Intervention for Adolescent
Children of Bipolar Mothers
H. Verdeli, L. Mufson, M.M. Weissman
207. Effect of a Novel Long-acting Antipsychotic
Formulation in Stable Patients with Schizoaffective Disorder
E. Vieta, G. Gharabawi, C. Bossie,
Y. Zhu, R. Lasser
208. Safety and Tolerability of Lamotrigine in
Bipolar I Disorder
E. Vieta, M. Berk, G. Asnis,
G. Sachs, C. Bowden, J. Calabrese
209. Neuropsychological Functioning of Children
Diagnosed with Bipolar Disorder
G.T. Voelbel, M.E. Bates, G. Pandina,
E. Frenkle, L. Hyers, R. Hendren
W
210. The Psychosocial Impact of Bipolar Disorders
K.D. Wagner, J.R.
Calabrese, R.M.A. Hirschfeld, M.A. Frye, M.
Reed
211. Psychosocial Impairment Associated with an
Arrest History Among People with Bipolar Disorder
K.D. Wagner, J.R.
Calabrese, R.M.A. Hirschfeld, M.A. Frye, M.
Reed
212. Treatment of Bipolar Disorders – A Psychoeducational Approach
P. Wagner, G. Dietrich, P. Bräunig
213. Psychopathologic Features of Rapid Cycling
Bipolar Patients
M.M. Wankmuller, K.H. Sutherland, L.E. Oakley,
J.F. Goldberg
214. Relation Between Anxiety and Sleep Quality
in Bipolar Disorder
C.A. Winett, S.L.
Johnson, T.A. Mellman, M.W. Otto
Y
215. Canadian Network for Bipolar Disorder
(CAN-BD): Preliminary Report of Data on the First 94 Patients
L.N. Yatham, P.
Cervantes, S. Beaulieu, M. Connolly, V.
Sharma
216. The Effects of Lithium and Lamotrigine in
Prevention of Relapse/Recurrence of Bipolar I Depression
L. Yatham, G. Goodwin,
C. Bowden, J. Calabrese, R. White, R. Leadbetter,
A. Metz
217. Topiramate Treatment of Comorbid Tourette’s
and Mood Disorders: Preliminary Report
C.M. Young, J.F Leckman, L.D. Scahill
218. Evaluating the Young Mania Rating Scale in a Comorbid Sample of Outpatients Age 5 to 17 Years
E.A. Youngstrom, C.K. Danielson, R.L. Findling,
J.R. Calabrese
219. Rating Scales Discriminate BPSD versus ADHD
in a Pre-Pubescent Clinical Sample
E.A. Youngstrom, R.L. Findling, S.Y. Kahana, C.
Demeter, M. Price, G.M. Woldorf, J.R. Calabrese
Z
220. Predictive Value of Anxiety Symptoms for the
Maintenance Treatment Response in Bipolar I Disorder
W. Zhang, R.A. Leadbetter, T.C. Spaulding,
Z. Antonijevic, J.R.T. Davidson, A. Metz
